Global Bone Densitometer Market

Global Bone Densitometer Market Set to Surge at 4.5% CAGR by 2026


Rising geriatric population, technological advancements in the field of bone densitometry, increasing incidents of fragility fracture, and a growing number of bone-related disorders are some of the key factors driving the global bone densitometer market. The high cost of bone densitometer devices, on the other hand, is projected to limit market expansion.

bone densitometer, commonly known as a dual-energy x-ray absorptiometry (DXA) machine, is a device that is used to determine the rate at which ionizing radiation is absorbed by a specific area of the skeleton. DXA is a straightforward, noninvasive method. A bone densitometer measures bone loss by using ultrasonography or X-rays to create images of the interior of the body (often the lower (or lumbar) spine and hips).

Rising Application of Dual-Energy X-ray Absorptiometry (DEXA) in Diverse Applications Propels the Bone Densitometer Market

DEXA is the preferred approach for diagnosing and monitoring osteoporosis since it evaluates the most important parameters objectively. It is also useful for determining body composition and its distribution by location. In recent years, additional applications have been discovered, such as vertebral morphometry through the study of the lateral spine, prosthesis integration in orthopedics, and lipodystrophy and lipoatrophy in HIV+ patients. In addition, DEXA is less costly than other imaging modalities, with significantly shorter scan periods and radiation exposure.

See also  Navigating the Growth Trajectory: The Global Diagnostic Imaging Market Outlook for 2028

Assessment of bone mineral density (BMD) in postmenopausal women fuels demand in the Bone Densitometer Market

Postmenopausal women are more prone to osteoporosis. This is because the decreased amount of estrogen hormone after menopause causes considerable bone loss. Several studies have shown that in the first five years after menopause, women lose up to 10% of their bone mass. It is regarded as the gold standard for diagnosing osteoporosis and predicting fracture risk utilizing algorithms such as the Fracture Risk Assessment Tool.

Adoption of Quantitative Ultrasound (QUS) for Estimating Bone Mineral Status in Children Increases Bone Densitometer Market Growth

QUS is a newer, noninvasive method of assessing bone mineral state in the peripheral skeleton. QUS techniques, in addition to bone density, give some structural information that may be useful in evaluating fracture risk. The QUS approach is safe, simple, and inexpensive. The gadgets are portable, the measurements take only a few minutes, and they are radiation-free. These QUS traits are especially useful in determining bone mineral status in youngsters.

See also  Revolutionizing Pediatric Interventional Cardiology: Embracing Innovation and Accessibility

To Explore more granular Bone Densitometer Market insights @

The Bone Densitometer Market is dominated by North America

North America dominates the bone densitometer market, followed by Europe and APAC. The growing incidence of osteoporosis, a well-developed healthcare infrastructure, technical improvements in bone densitometer devices, and the presence of significant market participants in the area all contribute to North America’s big position.

Competitive Landscape Analysis of the Bone Densitometer Market

Some of the major companies operating in the market include GE Healthcare, Hologic Inc., BeamMed Ltd., Echolight S.P.A, Scanflex Healthcare AB, and Medonica Co. Ltd, among others.

Companies Using Organic and Inorganic Growth tactics to Increase their Bone Densitometer Market Share

To gain market share, key players in this market are utilizing different business tactics such as collaborations, acquisitions, partnerships, and new product launches. For instance,

  • In February 2022, Echolight Medical and Aurora Spine Corporation signed a collaborative co-marketing agreement. The cooperative collaboration will most likely aid Aurora in combining Echolight’s bone health assessment capabilities with its unique DEXA Technology-based patient-matched implants, as well as in promoting Echolight’s products.
  • In July 2021, DMS Imaging announced the extension of its white-label manufacturing contract for the FUJIFILM Healthcare Group
See also  Global Contract Research Organization (CRO) Services Market is expected to grow at an 8% CAGR to $110 billion by 2026, up from $75 billion in 2021

To Explore more granular Bone Densitometer Market insights, please get in touch @

Leave a Reply

Your email address will not be published. Required fields are marked *